Search Results - "Dovholuk, A"
-
1
-
2
A phase Ib trial of ARQ 501, a selective checkpoint activator, in combination with docetaxel in patients with advanced solid tumors
Published in Journal of clinical oncology (20-06-2006)“…Abstract only 13053 Background: ARQ 501 is a DNA damage checkpoint activator. It directly activates DNA damage response pathways without inducing primary DNA…”
Get full text
Journal Article -
3
Phase 1 study of ARQ 197, a selective inhibitor of the c-Met RTK in patients with metastatic solid tumors reaches recommended phase 2 dose
Published in Journal of clinical oncology (20-06-2007)“…Abstract only 3525 Background: ARQ 197 is a selective inhibitor of the c-Met receptor tyrosine kinase, an oncogene implicated in tumor invasiveness,…”
Get full text
Journal Article -
4
-
5
-
6
AXENIC SEED CULTURE AND MICROPROPAGATION OF CYPRIPEDIUM REGINAE
Published in Selbyana (01-01-1997)“…An efficient method of axenic seed propagation of large numbers of Cypripedium reginae Walt, was developed as a means of supplying seedlings for a restoration…”
Get full text
Journal Article